What stage does DC Investment Partners invest at?

DC Investment Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is DC Investment Partners's typical check size?

DC Investment Partners typically writes checks of $10M.

Where is DC Investment Partners located?

DC Investment Partners is headquartered in McLean, US.

DC Investment Partners

Venture capital

McLean · Seed–Late Stage · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

DC Investment Partners backs early- and growth-stage companies, seeking businesses with strong leadership, demonstrated market acceptance, and a competitive edge. The firm aims to combine intellectual and financial capital to foster innovation. Beyond funding, it offers hands-on operational support—finance, human resources, recruiting, data analysis, and market research—to help companies that lack scale focus on value-added activities. Its team brings expertise in strategy consulting, business development, and investing, applying rigorous analytical methods to build sustainable business models and identify core profit drivers.

Invests inBiotech Consumer Data & Infrastructure Medical Devices Sector Agnostic SemiconductorsNorth AmericaUnited States

Source: firm website, verified Aug 7, 2026.

Stage

Seed–Late Stage

Check

$10M

McLean, Virginia, US

Instruments

Equity

Founded

2019

AUM

$2B

Tracked investments

Team · 7 people

from the firm's website & public directories

Mark A.· Managing Director & Advisor

Managing Director and advisor, and head of DC Investments Management, a proprietary hedge fund focused on global public markets. He was previously a Vice President at Dean & Company consulting for telecommunications, financial services, and media & entertainment companies.

Audrey· Vice Chair of the Board

Vice Chair of the Board with a background in R&D and business management. A University of Wisconsin-Madison graduate, she joined the investment team as an analyst and has expertise in biotechnology and health from work in epidemiology, toxicology, and animal science research. She is a former DC Energy analyst.

Dave· Chief Risk Officer

Chief Risk Officer who previously led investment teams at DC Energy. Prior to that he worked at a research group developing a supercomputer to model molecular interactions and consulted to biopharmaceutical firms.

Dean· Chair of the Board

Chair of the Board who has co-founded several firms including an energy trading firm, a financial exchange, and a consulting firm. He holds several patents, authored a business strategy text, served on the MIT faculty, and has experience across energy, telecommunications, technology, manufacturing, finance, and healthcare.

Jim· Deputy Chair of the Board

Deputy Chair of the Board and serial entrepreneur who has co-founded four companies, with over 20 years of investing experience in commodities and public and private equity across many industries. He was previously a strategy consultant.

Mark B.· President

President focused on building DC Investment Partners' portfolio. He previously served as a Director at DC Energy, co-founded Energy Clearing Services as Managing Director of operations, and developed key intellectual property including a US Patent that led to the founding of Nodal Exchange.

Mark Bulkeley· President· Washington, District of Columbiain

m•••@dcinvestmentpartners.comreveal

What they invest in

from 5 of 17 portfolio companies

Biotech ×2Medical Devices ×2AI & Machine Learning ×1Deep Tech ×1Defense Tech ×1Digital Health ×1Fintech ×1Hardware ×1

HQs:United States×3

Investments · 17 tracked

founders shown can be your intro path

By year:2021 · 1 2020 · 1 2019 · 13 dated

Aeolusaeolus.com

Ballisticventuresballisticventures.com

BE Biopharmabe.bio

Bounce Imagingbounceimaging.comin 𝕏Sep 2019

Bounce Imaging manufactures tactical 360-degree camera systems and robotics for first responders, law enforcement, and military personnel to safely assess confined spaces.

Defense TechHardwareRoboticsBuffalo, US

Francisco Aguilar(Executive Officer, Director)Ronjon Nag(Director)James Smist(Director)Sietse Dijkstra(Executive Officer)Mark Fargason(Executive Officer)Mikhail Fridberg(Executive Officer)

Carbon Biosciences, Inc. 次世代遺伝子治療ベクター・治療薬carbonbio.com

Clpgrowthclpgrowth.comin

Columbia Lake Partners (CLP) provides growth loans and venture debt to European technology companies.

Fintech

DEM BioPharmadembiopharma.com

Evolutionequityevolutionequity.com

Immunitas Therapeuticsimmunitastx.cominAug 2021

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)Juergen Eckhardt(Director)

BoardLaura Brass(Director)

Kandoukandou.comin 𝕏

Kandou AI develops high-speed, energy-efficient connectivity solutions for semiconductor and AI infrastructure, focusing on reducing system costs to enable scalable AI systems.

AI & Machine LearningDeep TechSemiconductors

Lassen Therapeuticslassentherapeutics.comin

Longwoodfundlongwoodfund.comin 𝕏

Qedinvestorsqedinvestors.com

Rectifypharmarectifypharma.comin 𝕏

The rule of Xbvp.com

visit www.interiusbio.cominteriusbio.com

Werewolf Therapeuticswerewolftx.comDec 2020

Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.

BiotechHealthtechMedical DevicesWatertown, US

Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))Daniel Hicklin(Executive Officer, Director)Alon Lazarus(Director)David Cordo(Executive Officer)

BoardChristoph Westphal(Director)

Portfolio news

latest coverage across their companies

Brown and White Ventures invests in startup Bounce Imaging

Bounce Imaging · buffalonews.com · Jul 10, 2026

Kandou AI Raises $225M in Series A Funding- EE Times

Kandou · eetimes.com · Apr 7, 2026

Frequently asked questions

What stage does DC Investment Partners invest at?: DC Investment Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is DC Investment Partners's typical check size?: DC Investment Partners typically writes checks of $10M.
What sectors does DC Investment Partners focus on?: DC Investment Partners focuses on Biotech, Consumer, Data & Infrastructure, Medical Devices, Sector Agnostic, Semiconductors.
Where is DC Investment Partners located?: DC Investment Partners is headquartered in McLean, US.

Images

Similar investors

IDG Capital

IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.

$3M – $200M

Mitsui Global Investment

Mitsui Global Investment is an investment firm that provides capital and hands-on support to entrepreneurs, helping innovative teams scale their businesses onto the global stage.

$500K – $10M

SBI Investment Korea Co. Ltd.

SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.

$2.5M – $33M

Industrial Technology Investment Corporation

Industrial Technology Investment Corporation is the venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), backing startups across multiple stages and sectors while providing access to ITRI's R&D resources.

$1.9M – $227M

Korea Investment Partners

Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.

$973K – $50M